Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4⁺CD25⁻CD69⁺ subset proliferation

References

• LiberalRGrantCRLonghiMSMieli-VerganiGVerganiDDiagnostic criteria of autoimmune hepatitisAutoimmun Rev2014134–543544024418295
   PubMed Web of Science ®Google Scholar
• ChenJEslickGDWeltmanMSystematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderlyAliment Pharmacol Ther201439211712424261965
   PubMed Web of Science ®Google Scholar
• FloreaniALiberalRVerganiDMieli-VerganiGAutoimmune hepatitis: contrasts and comparisons in children and adults – a comprehensive reviewJ Autoimmun20134671624035197
   PubMed Web of Science ®Google Scholar
• HeneghanMAYeomanADVermaSSmithADLonghiMSAutoimmune hepatitisLancet201338299021433144423768844
   PubMed Web of Science ®Google Scholar
• MiyaraMItoYSakaguchiSTREG-cell therapies for autoimmune rheumatic diseasesNat Rev Rheumatol201410954355124980140
   PubMed Web of Science ®Google Scholar
• LonghiMSMaYMitryRREffect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitisJ Autoimmun2005251637116005184
   PubMed Web of Science ®Google Scholar
• LonghiMSMaYBogdanosDPCheesemanPMieli-VerganiGVerganiDImpairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver diseaseJ Hepatol2004411313715246204
   PubMed Web of Science ®Google Scholar
• CzajaAJCurrent and prospective pharmacotherapy for autoimmune hepatitisExpert Opin Pharmacother201415121715173624961409
   PubMed Web of Science ®Google Scholar
• CarboneMNeubergerJMAutoimmune liver disease, autoimmunity and liver transplantationJ Hepatol201460121022324084655
   PubMed Web of Science ®Google Scholar
• ChatrathHAllenLBoyerTDUse of sirolimus in the treatment of refractory autoimmune hepatitisAm J Med2014127111128113124979741
   PubMed Web of Science ®Google Scholar
• YoshizawaKMatsumotoAIchijoTLong-term outcome of Japanese patients with type 1 autoimmune hepatitisHepatology201256266867622334246
   PubMed Web of Science ®Google Scholar
• JothimaniDCrampMEMitchellJDCrossTJTreatment of autoimmune hepatitis: a review of current and evolving therapiesJ Gastroenterol Hepatol201126461962721073674
   PubMed Web of Science ®Google Scholar
• FallatahHIAkbarHOMycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapyExpert Rev Gastroenterol Hepatol20115451752221780898
   PubMed Web of Science ®Google Scholar
• MingLJYinACTherapeutic effects of glycyrrhizic acidNat Prod Commun20138341541823678825
   PubMed Web of Science ®Google Scholar
• van RossumTGVultoAGde ManRABrouwerJTSchalmSWReview article: glycyrrhizin as a potential treatment for chronic hepatitis CAliment Pharmacol Ther19981231992059570253
   PubMed Web of Science ®Google Scholar
• HeYZengFLiuQProtective effect of magnesium isoglycyrrhizinate on ethanol-induced testicular injuries in miceJ Biomed Res201024215316023554626
   PubMedGoogle Scholar
• SunLShenJPangXLuLMaoYZengMPhase I safety and pharmacokinetic study of magnesium isoglycyrrhizinate after single and multiple intravenous doses in Chinese healthy volunteersJ Clin Pharmacol200747676777317409184
   PubMed Web of Science ®Google Scholar
• XieCLiXWuJAnti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase A2/arachidonic acid pathwayInflammation20153841639164825691139
   PubMed Web of Science ®Google Scholar
• HuangXQinJLuSMagnesium isoglycyrrhizinate protects hepatic L02 cells from ischemia/reperfusion induced injuryInt J Clin Exp Pathol2014784755476425197346
   PubMed Web of Science ®Google Scholar
• ChengYZhangJShangJZhangLPrevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitroPharmacology200984318319019752584
   PubMed Web of Science ®Google Scholar
• KnodellRGIshakKGBlackWCFormulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisHepatology1981154314357308988
   PubMed Web of Science ®Google Scholar
• MatheuMPCahalanMDIsolation of CD4+ T cells from mouse lymph nodes using Miltenyi MACS purificationJ Vis Exp2007940918989449
   PubMedGoogle Scholar
• LerchMMConwellDLMayerleJThe anti-inflammasome effect of lactate and the lactate GPR81-receptor in pancreatic and liver inflammationGastroenterology201414671602160524780214
   PubMed Web of Science ®Google Scholar
• HondaHNagaiYMatsunagaTIsoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammationJ Leukoc Biol20149661087110025210146
   PubMed Web of Science ®Google Scholar
• YükselMLaukensDHeindryckxFHepatitis mouse models: from acute-to-chronic autoimmune hepatitisInt J Exp Pathol201495530932025112417
   PubMed Web of Science ®Google Scholar
• HanYGuoQZhangMChenZCaoXCD69+ CD4+ CD25− T cells, a new subset of regulatory T cells, suppress T-cell proliferation through membrane-bound TGF-beta 1J Immunol2009182111112019109141
   PubMed Web of Science ®Google Scholar
• ZhuJFengASunJIncreased CD4(+) CD69(+) CD25(−) T cells in patients with hepatocellular carcinoma are associated with tumor progressionJ Gastroenterol Hepatol201126101519152621557772
   PubMed Web of Science ®Google Scholar
• XuDWangFSAre non-traditional CD4(+) CD69(+) CD25(−) regulatory T cells involved in disease progression of human hepatocellular carcinoma?J Gastroenterol Hepatol201126101469147021950742
   PubMed Web of Science ®Google Scholar
• ZhaoXSWangXHZhaoXYNon-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantationJ Transl Med20141218724984576
   PubMed Web of Science ®Google Scholar
• DegauqueNLairDBraudeauCDevelopment of CD25− regulatory T cells following heart transplantation: evidence for transfer of long-term survivalEur J Immunol200737114715617171754
   PubMed Web of Science ®Google Scholar
• LuSYHuangXJLiuKYLiuDHXuLPHigh frequency of CD4+ CD25− CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplantsClin Transplant2012262E158E16722507356
   PubMed Web of Science ®Google Scholar
• GracaLThompsonSLinCYAdamsECobboldSPWaldmannHBoth CD4(+)CD25(+) and CD4(+)CD25(−) regulatory cells mediate dominant transplantation toleranceJ Immunol2002168115558556512023351
   PubMed Web of Science ®Google Scholar
• HallBMRobinsonCMPlainKMStudies on naïve CD4+CD25+ T cells inhibition of naïve CD4+CD25− T cells in mixed lymphocyte culturesTranspl Immunol200818429130118158114
   PubMed Web of Science ®Google Scholar